Limei Shen

2.4k total citations · 1 hit paper
39 papers, 2.0k citations indexed

About

Limei Shen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Limei Shen has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Limei Shen's work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (6 papers). Limei Shen is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (6 papers). Limei Shen collaborates with scholars based in United States, China and Germany. Limei Shen's co-authors include Leaf Huang, Wantong Song, Rihe Liu, Tyler J. Goodwin, Xueqiong Zhang, Yun Liu, Ying Wang, Lin Hou, Qi Liu and Fengqian Chen and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Limei Shen

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

2018 345 citations Wantong Song, Limei Shen et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Limei Shen United States	21	867	667	600	597	388	39	2.0k
Min Luo China	16	1.2k 1.4×	786 1.2×	820 1.4×	427 0.7×	289 0.7×	25	2.0k
Mengze Lv China	9	1.7k 2.0×	689 1.0×	1.1k 1.9×	345 0.6×	209 0.5×	9	2.6k
Yukun Guan United States	15	1.8k 2.0×	691 1.0×	1.1k 1.8×	322 0.5×	203 0.5×	31	2.7k
Mee Rie Sheen United States	21	454 0.5×	344 0.5×	760 1.3×	302 0.5×	174 0.4×	31	1.7k
Zhiyao He China	32	306 0.4×	580 0.9×	1.8k 2.9×	343 0.6×	561 1.4×	88	3.0k
Jiayin Shen China	21	317 0.4×	400 0.6×	725 1.2×	503 0.8×	94 0.2×	53	1.8k
Vyara Matson United States	8	717 0.8×	380 0.6×	1.9k 3.1×	1.6k 2.7×	337 0.9×	8	3.4k
Ninh M. La‐Beck United States	19	349 0.4×	634 1.0×	603 1.0×	504 0.8×	766 2.0×	43	1.8k
Meng Zhou China	20	415 0.5×	349 0.5×	890 1.5×	261 0.4×	450 1.2×	46	1.9k
Victor Moyo United States	25	311 0.4×	270 0.4×	384 0.6×	313 0.5×	303 0.8×	69	2.1k

Countries citing papers authored by Limei Shen

Since Specialization

Citations

This map shows the geographic impact of Limei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Shen more than expected).

Fields of papers citing papers by Limei Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Shen. The network helps show where Limei Shen may publish in the future.

Co-authorship network of co-authors of Limei Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Limei Shen. A scholar is included among the top collaborators of Limei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Shen. Limei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Limei, Alison Schaefer, Justin T. Huckaby, Whitney Wolf, & Samuel K. Lai. (2025). Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. Theranostics. 15(12). 5529–5542. 1 indexed citations

Zhang, Hongyan, Jingyi Huang, Yujie Li, et al.. (2025). Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma. Acta Pharmaceutica Sinica B. 15(5). 2687–2702. 3 indexed citations

Shen, Limei, et al.. (2024). Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine. ACS Nano. 18(12). 8733–8744. 14 indexed citations

Shen, Limei, Alison Schaefer, Karthik Tiruthani, Whitney Wolf, & Samuel K. Lai. (2024). Siglec15/ TGF ‐β bispecific antibody mediates synergistic anti‐tumor response against 4T1 triple negative breast cancer in mice. Bioengineering & Translational Medicine. 9(5). e10651–e10651. 1 indexed citations

Togami, Kohei, Whitney Wolf, Limei Shen, et al.. (2024). Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium. Frontiers in Immunology. 15. 1371156–1371156. 2 indexed citations

Li, Yujie, et al.. (2024). Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy. Acta Pharmaceutica Sinica B. 14(11). 4717–4737. 17 indexed citations

Li, Zhongbo, Limei Shen, Alice Ma, et al.. (2023). Pegloticase co-administered with high MW polyethylene glycol effectively reduces PEG-immunogenicity and restores prolonged circulation in mouse. Acta Biomaterialia. 170. 250–259. 12 indexed citations

Liu, Yun, Nasha Qiu, Limei Shen, et al.. (2020). Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. Journal of Controlled Release. 323. 431–441. 49 indexed citations

McSweeney, Morgan D., et al.. (2020). Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice. Journal of Controlled Release. 329. 774–781. 36 indexed citations

10.

Qiu, Nasha, Yun Liu, Qi Liu, et al.. (2020). Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 269. 120604–120604. 77 indexed citations

11.

Zhang, Xueqiong, Limei Shen, Qi Liu, Lin Hou, & Leaf Huang. (2019). Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors. Journal of Controlled Release. 309. 173–180. 42 indexed citations

12.

Shen, Limei, Stefan Tenzer, Moritz Hess, et al.. (2018). Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells. PLoS ONE. 13(2). e0192541–e0192541. 3 indexed citations

13.

Hou, Lin, Qi Liu, Limei Shen, et al.. (2018). Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma. Theranostics. 8(14). 3781–3796. 79 indexed citations

14.

Song, Wantong, Limei Shen, Ying Wang, et al.. (2018). Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nature Communications. 9(1). 2237–2237. 345 indexed citations breakdown →

15.

Das, Manisit, Limei Shen, Qi Liu, Tyler J. Goodwin, & Leaf Huang. (2018). Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer. Molecular Therapy. 27(3). 507–517. 77 indexed citations

16.

Han, Lifeng, Adrienne N. Poon, Keming Rou, et al.. (2015). Differences in risk behaviours and HIV/STI prevalence between low-fee and medium-fee female sex workers in three provinces in China. Sexually Transmitted Infections. 92(4). 309–315. 20 indexed citations

17.

Shen, Limei, Tetsuya Higuchi, Ingrid Tubbe, et al.. (2013). A Trifunctional Dextran-Based Nanovaccine Targets and Activates Murine Dendritic Cells, and Induces Potent Cellular and Humoral Immune Responses In Vivo. PLoS ONE. 8(12). e80904–e80904. 22 indexed citations

18.

Ma, Wei, Zunyou Wu, Yi Qin, et al.. (2008). A Comparison of Voluntary Counseling and Testing Uptake Between a China CARES County and a County Not Designated for the China CARES Program. AIDS Patient Care and STDs. 22(6). 521–533. 7 indexed citations

19.

Liu, Enwu, Limei Shen, Huan Zhong, et al.. (2008). Correlates of methadone client retention: A prospective cohort study in Guizhou province, China. International Journal of Drug Policy. 20(4). 304–308. 40 indexed citations

20.

Ma, Wei, Roger Detels, Yuji Feng, et al.. (2007). Acceptance of and barriers to voluntary HIV counselling and testing among adults in Guizhou province, China. AIDS. 21(Suppl 8). S129–S135. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact